CMA lawyer: Pfizer and Flynn prices rocketed

A barrister representing the UK’s Competition and Markets Authority today said the enforcer can prove Pfizer and Flynn acted illegally in raising the price of phenytoin capsules by looking at “dramatic” increase in prices after 2012 – and said the conduct is also illegal under the classic United Brands test.

Get unlimited access to all Global Competition Review content